Skip to main content
. 2020 Sep 18;15(10):1403–1412. doi: 10.2215/CJN.00150120

Table 2.

Prevalence of CKD, low eGFR, high urinary albumin-creatinine ratio, and hypertension by postoperative AKI status, from 3 mo to 4 yr after cardiac surgery discharge

Outcomes Outcome Prevalence by Presence of Postoperative AKI Stage 1 or Worse versus No AKI, n/total (%)
3 Mo 12 Mo 24 Mo 36 Mo 48 Mo
AKI No AKI AKI No AKI AKI No AKI AKI No AKI AKI No AKI
CKD 12/49 (24) 10/60 (17) 15/51 (29) 17/59 (29) 10/48 (21) 14/56 (25) 8/43 (19) 10/55 (18) 7/42 (17) 9/54 (17)
Low eGFRa 2/51 (4) 4/61 (7) 2/53 (4) 5/58 (9) 1/49 (2) 3/56 (5) 1/45 (2) 3/54 (6) 0/43 (0) 5/53 (9)
High UACRa 11/54 (20) 7/65 (11) 13/52 (25) 12/62 (19) 9/52 (17) 12/58 (21) 8/47 (17) 7/57 (12) 7/45 (16) 4/56 (7)
Systolic and/or diastolic hypertension 19/45 (42)b 14/64 (22) 22/45 (49)c 10/57 (18) 15/47 (32) 13/59 (22) 9/44 (20) 12/56 (21) 11/46 (24) 12/57 (21)
Hypertension and/or CKDa 29/46 (63)b 22/59 (37) 27/46 (59) 23/58 (40) 21/44 (48) 24/56 (43) 15/40 (38) 20/54 (37) 16/42 (38) 18/55 (33)
Outcomes Outcome Prevalence by Presence of Postoperative AKI Stage 2 or Worse versus No AKI or Stage 1 AKI, n/total (%)
3 Mo 12 Mo 24 Mo 36 Mo 48 Mo
≥Stage 2 AKI No AKI or Stage 1 ≥Stage 2 AKI No AKI or Stage 1 ≥Stage 2 AKI No AKI or Stage 1 ≥Stage 2 AKI No AKI or Stage 1 ≥Stage 2 AKI No AKI or Stage 1
CKD 5/23 (22) 17/86 (20) 8/24 (33) 24/86 (28) 2/23 (9) 22/81 (27) 5/17 (29) 13/81 (16) 3/18 (17) 13/78 (17)
Low eGFRa 2/23 (9) 4/89 (5) 1/26 (4) 6/85 (7) 0/24 (0) 4/81 (5) 1/19 (5) 3/80 (4) 0/19 (0) 5/77 (6)
High UACRa 4/27 (15) 14/92 (15) 7/25 (28) 18/89 (20) 2/25 (8) 19/85 (22) 5/20 (25) 10/84 (12) 3/20 (15) 8/81 (10)
Systolic and/or diastolic hypertension 11/22b (50) 22/87 (25) 14/22c (64) 18/80 (23) 8/22 (36) 20/84 (24) 5/20 (25) 16/80 (20) 6/21 (29) 17/82 (21)
Hypertension and/or CKDa 14/21 (67) 37/84 (44) 15/22b (68) 35/82 (43) 8/20 (40) 37/80 (46) 9/17 (53) 26/77 (34) 8/18 (44) 26/79 (33)

CKD defined as low GFR, estimated using serum creatinine or high UACR. UACR, urinary albumin-creatinine ratio.

a

Note that composite outcome participant numbers will differ from the numbers for the components of the composite outcomes (e.g., CKD total, versus totals for low eGFR and high UACR).

b

P<0.05

c

P<0.005, for difference in proportion with outcome between AKI and non-AKI groups or between stage 2 or worse AKI versus no AKI/stage 1 groups.